SCM
ITCI
Silverarc Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-179,085
| Closed | -$15M | – | 81 |
|
|
2024
Q4 | $15M | Buy |
179,085
+11,975
| +7% | +$1M | 3.27% | 12 |
|
|
2024
Q3 | $12.2M | Sell |
167,110
-25,235
| -13% | -$1.85M | 2.75% | 10 |
|
|
2024
Q2 | $13.2M | Buy |
192,345
+157,538
| +453% | +$10.8M | 3.11% | 9 |
|
|
2024
Q1 | $2.41M | Sell |
34,807
-45,193
| -56% | -$3.13M | 0.67% | 44 |
|
|
2023
Q4 | $5.73M | Sell |
80,000
-128,730
| -62% | -$9.22M | 1.71% | 20 |
|
|
2023
Q3 | $10.9M | Buy |
208,730
+10,007
| +5% | +$521K | 3.3% | 5 |
|
|
2023
Q2 | $12.6M | Buy |
198,723
+73,688
| +59% | +$4.67M | 3.89% | 6 |
|
|
2023
Q1 | $6.77M | Sell |
125,035
-15,331
| -11% | -$830K | 2.79% | 10 |
|
|
2022
Q4 | $7.43M | Buy |
140,366
+4,240
| +3% | +$224K | 2.13% | 11 |
|
|
2022
Q3 | $6.33M | Sell |
136,126
-177,836
| -57% | -$8.27M | 2.14% | 13 |
|
|
2022
Q2 | $17.9M | Buy |
313,962
+5,143
| +2% | +$294K | 5.52% | 1 |
|
|
2022
Q1 | $18.9K | Buy |
308,819
+113,819
| +58% | +$6.97K | 7.82% | 2 |
|
|
2021
Q4 | $10.2M | Buy |
195,000
+93,110
| +91% | +$4.87M | 4.14% | 3 |
|
|
2021
Q3 | $3.8M | Sell |
101,890
-11,368
| -10% | -$424K | 2.15% | 14 |
|
|
2021
Q2 | $4.62K | Sell |
113,258
-16,859
| -13% | -$688 | 2.06% | 14 |
|
|
2021
Q1 | $4.42M | Sell |
130,117
-69,883
| -35% | -$2.37M | 2.41% | 11 |
|
|
2020
Q4 | $6.36M | Buy |
+200,000
| New | +$6.36M | 3.7% | 2 |
|